← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Designmedix, Inc.
Portland, OR
$5,471,056
Total funding
6
Grants
Funding over time
peak $1.3M · FY2007–16$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,471,056 · 6
By mechanism
R42$4,310,664 · 2
R41$1,057,778 · 3
R43$102,614 · 1
Investigators at Designmedix, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
Preclinical development of novel small molecule malaria drugs that overcome drug$999,700
R42 · FY2015 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug$994,275
R42 · FY2016 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug$989,081
R42 · FY2014 · AI
Designed Antimalarial Agents Overcoming Chloroquine-Resistance$682,835
R42 · FY2009 · AI
Designed Antimalarial Agents Overcoming Chloroquine-Resistance$644,773
R42 · FY2010 · AI
High-potency nitro antimicrobials for topical treatment of trichomoniasis$353,902
R41 · FY2016 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug$300,000
R41 · FY2012 · AI
Preclinical development of novel small molecule malaria drugs that overcome drug$300,000
R41 · FY2011 · AI
Designed Antimalarial Agents Overcoming Chloroquine-Resistance$103,876
R41 · FY2007 · AI
Optimization of a novel antimalarial drug candidate for plant-scale synthesis$102,614
R43 · FY2012 · AI